4.8 Article

Posterior Neocortex-Specific Regulation of Neuronal Migration by CEP85L Identifies Maternal Centriole-Dependent Activation of CDK5

期刊

NEURON
卷 106, 期 2, 页码 246-+

出版社

CELL PRESS
DOI: 10.1016/j.neuron.2020.01.030

关键词

-

资金

  1. Manton Center for Orphan Disease Research from the NINDS [R01NS035129, R01NS032457]
  2. Allen Discovery Center program through The Paul G. Allen Frontiers Group
  3. William Randolph Hearst Fund
  4. Charles Hood Foundation
  5. Child Health Research Career Development Award Program [K12 HD052896]
  6. NIH [T32GM007753]
  7. HCBI Simmons Award
  8. National Human Genome Research Institute
  9. National Eye Institute
  10. National Heart, Lung and Blood Institute [UM1 HG008900]
  11. Australian Genomics Health Alliance [GNT1113531]
  12. NHMRC, a Maurice de Rohan international scholarship
  13. Australian Government Research Training Program scholarship
  14. National Science Centre, Poland [2015/19/B/NZ2/01824]
  15. [R21NS104633-01A1]

向作者/读者索取更多资源

Genes mutated in human neuronal migration disorders encode tubulin proteins and a variety of tubulin-binding and -regulating proteins, but it is very poorly understood how these proteins function together to coordinate migration. Additionally, the way in which regional differences in neocortical migration are controlled is completely unknown. Here we describe a new syndrome with remarkably region-specific effects on neuronal migration in the posterior cortex, reflecting de novo variants in CEP85L. We show that CEP85L is required cell autonomously in vivo and in vitro for migration, that it localizes to the maternal centriole, and that it forms a complex with many other proteins required for migration, including CDK5, LIS1, NDE1, KIF2A, and DYNC1H1. Loss of CEP85L disrupts CDK5 localization and activation, leading to centrosome disorganization and disrupted microtubule cytoskeleton organization. Together, our findings suggest that CEP85L highlights a complex that controls CDK5 activity to promote neuronal migration.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Dermatology

Characterizing dermatologic findings among patients with PTEN hamartoma tumor syndrome: Results of a multicenter cohort study

Frederick C. Morgan, Lamis Yehia, Christine McDonald, Julian A. Martinez-Agosto, Antonio Y. Hardan, Joan Tamburro, Mustafa Sahin, Cheryl Bayart, Charis Eng

Summary: This study characterized the dermatologic findings and genotype-dermatologic phenotype associations in PTEN hamartoma tumor syndrome (PHTS). The results showed that children were less likely to have oral papillomas, vascular malformations, benign follicular neoplasms, and acral keratoses compared to adults. There were no cases of skin cancer among children. Basal cell carcinoma, cutaneous squamous cell carcinoma, and melanoma developed in a small percentage of White adults. Missense mutations were associated with lower odds of developing certain cutaneous manifestations after adjusting for age.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2023)

Review Genetics & Heredity

Interpreting variants in genes affected by clonal hematopoiesis in population data

Sanna Gudmundsson, Colleen M. Carlston, Anne O'Donnell-Luria

Summary: Reference population databases such as gnomAD have improved our ability to interpret the human genome, but clonal hematopoiesis (CH) poses challenges in variant interpretation. Somatic variants associated with CH can affect variant frequencies and downstream filtering. Filtering variants or genes associated with CH may inadvertently exclude true germline variants and cause Mendelian conditions. Here, we provide insights and recommendations for interpreting population variant data in genes affected by CH, specifically focusing on 36 established CH genes associated with neurodevelopmental conditions.

HUMAN GENETICS (2023)

Article Biochemistry & Molecular Biology

Genomic autopsy to identify underlying causes of pregnancy loss and perinatal death

Alicia B. Byrne, Peer Arts, Thuong T. Ha, Karin S. Kassahn, Lynn S. Pais, Anne O'Donnell-Luria, Milena Babic, Mahalia S. B. Frank, Jinghua Feng, Paul Wang, David M. Lawrence, Leila Eshraghi, Luis Arriola, John Toubia, Hung Nguyen, George McGillivray, Jason Pinner, Fiona McKenzie, Rebecca Morrow, Jill Lipsett, Nick Manton, T. Yee Khong, Lynette Moore, Jan E. Liebelt, Andreas W. Schreiber, Sarah L. King-Smith, Tristan S. E. Hardy, Matilda R. Jackson, Christopher P. Barnett, Hamish S. Scott, Francois Aguet, Harindra M. Arachchi, Christina A. Austin-Tse, Larry Babb, Samantha M. Baxter, Harrison Brand, Alicia B. Byrne, Jaime Chang, Katherine R. Chao, Ryan L. Collins, Beryl Cummings, Kayla Delano, Stephanie P. DiTroia, Eleina England, Emily Evangelista, Selin Everett, Laurent C. Francioli, Jack Fu, Vijay S. Ganesh, Kiran Garimella, Laura D. Gauthier, Julia K. Goodrich, Sanna Gudmundsson, Stacey J. Hall, Yongqing Huang, Steve Jahl, Kristen M. Laricchia, Kathryn E. Larkin, Monkol Lek, Gabrielle Lemire, Rachel B. Lipson, Alysia Kern Lovgren, Daniel G. MacArthur, Brian E. Mangilog, Stacy Mano, Jamie L. Marshall, Thomas E. Mullen, Kevin K. Nguyen, Emily O'Heir, Melanie C. O'Leary, Ikeoluwa A. Osei-Owusu, Lynn S. Pais, Jorge Perez de Acha Chavez, Emma Pierce-Hoffman, Heidi L. Rehm, Milan Serrano, Moriel Singer-Berk, Hana Snow, Matthew Solomonson, Rachel G. Son, Abigail Sveden, Michael Talkowski, Grace Tiao, Miriam S. Udler, Zaheer Valivullah, Elise Valkanas, Grace E. VanNoy, Qingbo S. Wang, Nicholas A. Watts, Ben Weisburd, Clara E. Williamson, Michael W. Wilson, Lauren Witzgall, Monica H. Wojcik, Isaac Wong, Jordan C. Wood, Shifa Zhang, Disna Abeysuriya, Lesley C. Ades, David J. Amor, Susan Arbuckle, Madhura Bakshi, Christopher P. Barnete, Bligh Berry, Tiffany Boughtwood, Adam Bournazos, Alessandra Bray, Fiona Chan, Yuen Chan, Clara Chung, Jonathan Clark, Jackie Collett, Alison Colley, Felicity Collins, Sandra Cooper, Mark A. Corbett, Jane E. Dahlstrom, Peter Dargaville, Janene Davies, Tenielle Davis, Jarrad Dearman, Jayanthi Dissanayake, Julia Dobbins, Helen Doyle, Andrew Dubowsky, Matt Edwards, Lisa J. Ewans, Mitali Fadia, Andrew Fennell, Ken Finlay, Andrew French, Kathryn Friend, Alison E. Gardner, Jozef Gecz, Nicole Graf, Eric A. Haan, Georgina Hollingsworth, Ari E. Horton, Denise Howting, Matthew F. Hunter, Gareth Jevon, Benjamin Kamien, Debra Kennedy, T. Yee Khong, Michael Krivanek, Thessa Kroes, Emma Krzesinski, Edward Kwan, Stephanie Lau, Shannon LeBlanc, Jan Liebelt, Suzanna Lindsey-Temple, Jill Lipsett, Christine K. C. Loo, Julia Low, Amali Mallawaarachchi, Nick Manton, Admire Matsika, Tessa Mattiske, Julie McGaughran, George McGillivray, Lesley McGregor, Fiona McKenzie, Namita Mittal, Ali Moghimi, Lynette Moore, Hatice Mutlu Albayrak, Jessica Ng, Jillian Nicholl, Nicholas Pachter, John Papadimitriou, Renae Parker, Sarah Parsons, Chirag Patel, Rhonda Pawlowski, Luis A. Perez-Jurado, Jason R. Pinner, Katerina Politis, Cathryn Poulton, Theresa Power, Michael Quinn, Sulekha Rajagopalan, Matthew Regan, Jonathan Rodgers, Steuart Rorke, Rani Sachdev, Suzanne Sallevelt, Sarah A. Sandaradura, Maryam Shamassi, Roshan Shamon, Isabella Sherburn, Ennie Slee, Annalisa Solinas, Ella Sugo, Elizabeth Thompson, Sagarika Tripathy, Anand Vasudevan, Melisa Vazquez, Kunal Verma, Mthulisi Viki, Mathew Wallis, Dani L. Webber, Martin Weber, Karen Whale, Meredith Wilson, Lisa Worgan, Sui Yu

Summary: We evaluated 'genomic autopsy' as an adjunct to standard autopsy for families who experienced fetal or newborn death. The study provided genetic diagnoses for 105 families, revealing severe atypical in utero presentations of known genetic disorders and identifying novel phenotypes and disease genes. Our findings emphasize the clinical importance of genomic investigations in pregnancy loss and perinatal death, highlighting the potential for accurate counseling in future pregnancies.

NATURE MEDICINE (2023)

Editorial Material Clinical Neurology

Does SARS-CoV-2 Cause Seizures and Epilepsy in COVID-19 via Inflammation or by Direct Infection?

David G. Vossler

EPILEPSY CURRENTS (2023)

Editorial Material Clinical Neurology

Midazolam, Ketamine, and Propofol: While We Slept, Others Worked on Anesthetizing Infusions for Refractory Status Epilepticus

David G. Vossler

Summary: This study aimed to compare the efficacy of midazolam and propofol in treating refractory status epilepticus (RSE) and focused on management methods in resource-limited settings. The study found that patients treated with midazolam or propofol for RSE had similar baseline characteristics and outcomes. Prolonged EEG monitoring may help reduce the duration of anesthetic infusions, but this depends on the implementation of RSE management protocols.

EPILEPSY CURRENTS (2023)

Letter Cardiac & Cardiovascular Systems

National Human Genome Research Institute Genomic Data Science Analysis, Visualization, and Informatics Lab-Space: Reaching out to Clinicians

Jennifer L. Hall, Sally Honeycutt, Nicole Gonzalez, Anne O'Donnell-Luria, Casey Overby Taylor, Laura Stevens, Anthony A. Philippakis, Michael C. Schatz

CIRCULATION-GENOMIC AND PRECISION MEDICINE (2023)

Review Genetics & Heredity

Updated consensus guidelines on the management of Phelan-McDermid syndrome

Siddharth Srivastava, Mustafa Sahin, Joseph D. Buxbaum, Elizabeth Berry-Kravis, Latha Valluripalli Soorya, Audrey Thurm, Jonathan A. Bernstein, Afua Asante-Otoo, William E. E. Bennett Jr, Catalina Betancur, Tegwyn H. Brickhouse, Maria Rita Passos Bueno, Maya Chopra, Celanie K. Christensen, Jennifer L. Cully, Kira Dies, Kate Friedman, Brittany Gummere, J. Lloyd Holder Jr, Andres Jimenez-Gomez, Carolyn A. Kerins, Omar Khan, Teresa Kohlenberg, Ronald V. Lacro, Lori A. Levi, Tess Levy, Diane Linnehan, Loth Eva, Baharak Moshiree, Ann Neumeyer, Scott M. Paul, Katy Phelan, Antonio Persico, Robert Rapaport, Curtis Rogers, Jeffrey Saland, Swathi Sethuram, Janine Shapiro, Phillip I. Tarr, Kerry M. White, Jordan Wickstrom, Kent M. Williams, Dana Winrow, Brian Wishart, Alexander Kolevzon

Summary: Phelan-McDermid syndrome (PMS) is a genetic condition caused by SHANK3 haploinsufficiency and characterized by a wide range of neurodevelopmental and systemic manifestations. Updated clinical management guidelines have been established to reflect the latest knowledge in PMS and provide guidance for clinicians, researchers, and the general community. These guidelines were developed by a taskforce consisting of clinical experts in PMS and representatives from the parent community.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2023)

Article Genetics & Heredity

Development of webcam-collected and artificial-intelligence-derived social and cognitive performance measures for neurodevelopmental genetic syndromes

Thomas W. Frazier, Robyn M. Busch, Patricia Klaas, Katherine Lachlan, Shafali Jeste, Alexander Kolevzon, Eva Loth, Jacqueline Harris, Leslie Speer, Tom Pepper, Kristin Anthony, Graglia J. Michael, Christal G. Delagrammatikas, Sandra Bedrosian-Sermone, Constance Smith-Hicks, Katie Huba, Robert Longyear, LeeAnne Green-Snyder, Frederick Shic, Mustafa Sahin, Charis Eng, Antonio Y. Hardan, Mirko Uljarevic

Summary: This study developed and evaluated a set of online, webcam-collected, and artificial intelligence-derived patient performance measures for neurodevelopmental genetic syndromes (NDGS). Four stimulus paradigms capturing social and cognitive processes were developed and administered to 375 participants. The measures showed good completion rates and internal consistency reliability. Test-retest reproducibility was fair to good and gaze-based measures demonstrated convergent and discriminant validity. The study also identified distinct patterns of social and cognitive functioning among different NDGS groups.

AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2023)

Article Clinical Neurology

Sustainability of seizure reduction and seizure control with adjunctive cenobamate: Post hoc analysis of a phase 3, open-label study

David G. G. Vossler, William E. E. Rosenfeld, Sean Stern, Clarence T. T. Wade, Louis Ferrari, Wesley T. T. Kerr, Robert Wechsler

Summary: In this post hoc analysis, the sustainability of seizure reduction with cenobamate was evaluated in patients with uncontrolled focal seizures. The results demonstrated that cenobamate can lead to sustained seizure reduction, with some patients achieving complete seizure control.

EPILEPSIA (2023)

Correction Biochemistry & Molecular Biology

Genomic autopsy to identify underlying causes of pregnancy loss and perinatal death ( jan, pg - 180 ,2023)

Alicia B. Byrne, Peer Arts, Thuong T. Ha, Karin S. Kassahn, Lynn S. Paris, Anne O'Donnell-Luria, Milena Babic, Mahalia S. B. Frank, Jinghua Feng, Paul Wang, David M. Lawrence, Leila Eshraghi, Luis Arriola, John Toubia, Hung Nguyen, George McGillivray, Jason Pinner, Fiona McKenzie, Rebecca Morrow, Jill Lipsett, Nick Manton, T. Yee Khong, Lynette Moore, Jan E. Liebelt, Andreas W. Schreiber, Sarah L. King-Smith, Tristan S. E. Hardy, Matilda R. Jackson, Christopher P. Barnett, Hamish S. Scott, Broad Inst Ctr Mendelian Genomics, Genomic Autopsy Study Res Network

NATURE MEDICINE (2023)

Article Cell Biology

Increased degradation of FMRP contributes to neuronal hyperexcitability in tuberous sclerosis complex

Kellen D. Winden, Truc T. Pham, Nicole A. Teaney, Juan Ruiz, Ryan Chen, Cidi Chen, Mustafa Sahin

Summary: Autism spectrum disorder (ASD) is a prevalent neurodevelopmental disorder, and understanding its pathological mechanisms is crucial for new therapies. Studies have shown that alterations in mechanistic target of rapamycin (mTOR) and fragile X messenger ribonucleoprotein 1 (FMRP) are associated with ASD development in TSC and fragile X syndrome. This study demonstrates that FMRP dysregulation plays a significant role in the abnormal neuronal activity in TSC, highlighting a molecular convergence between these two neurogenetic disorders.

CELL REPORTS (2023)

Article Clinical Neurology

Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy

Jacqueline A. French, Roger J. Porter, Emilio Perucca, Martin J. Brodie, Michael A. Rogawski, Simon Pimstone, Ernesto Aycardi, Cynthia Harden, Jenny Qian, Constanza Luzon Rosenblut, Christopher Kenney, Gregory N. Beatch

Summary: This phase 2b clinical trial showed that treatment with XEN1101 led to a significant and dose-dependent reduction in monthly seizure frequency in adults with focal-onset seizures. The results support the further development of XEN1101 for the treatment of FOSs.

JAMA NEUROLOGY (2023)

Article Clinical Neurology

Seizure reduction in TSC2-mutant mouse model by an mTOR catalytic inhibitor

Sameer C. Dhamne, Meera E. Modi, Audrey Gray, Simone Bonazzi, Lucas Craig, Elizabeth Bainbridge, Lahin Lalani, Chloe E. Super, Samantha Schaeffer, Ketthsy Capre, Danuta Lubicka, Guiqing Liang, Doug Burdette, Stephanie M. McTighe, Sarika Gurnani, Sheryl Anne D. Vermudez, Daniel Curtis, Christopher J. Wilson, Mustafa Q. Hameed, Angelica D'Amore, Alexander Rotenberg, Mustafa Sahin

Summary: This study tested the efficacy of a novel mTOR catalytic inhibitor (TC1) in the treatment of TSC and found that it reduced seizure burden, extended survival, and restored normal weight gain in Tsc2 hypomorphic mice. Therefore, TC1 shows promise as a therapeutic option for TSC.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2023)

Article Medicine, Research & Experimental

Intrathecal AAV9/AP4M1 gene therapy for hereditary spastic paraplegia 50 shows safety and efficacy in preclinical studies

Xin Chen, Thomas Dong, Yuhui Hu, Raffaella De Pace, Rafael Mattera, Kathrin Eberhardt, Marvin Ziegler, Terry Pirovolakis, Mustafa Sahin, Juan S. Bonifacino, Darius Ebrahimi-Fakhari, Steven J. Gray

Summary: Spastic paraplegia 50 (SPG50) is an ultrarare childhood-onset neurological disorder caused by biallelic loss-of-function variants in the AP4M1 gene. In preclinical studies, adeno-associated virus (AAV)/AP4M1 gene therapy showed promising results in rescuing the symptoms of SPG50. The therapy was effective in transducing patient-derived fibroblasts and demonstrated dose-dependent effects in Ap4m1-KO mice, supporting the potential for a clinical trial in treating SPG50 through intrathecal administration of AAV9/AP4M1.

JOURNAL OF CLINICAL INVESTIGATION (2023)

Article Genetics & Heredity

Large 22q13.3 deletions perturb peripheral transcriptomic and metabolomic profiles in Phelan-McDermid syndrome

Michael S. Breen, Xuanjia Fan, Tess Levy, Rebecca M. Pollak, Brett Collins, Aya Osman, Anna S. Tocheva, Mustafa Sahin, Elizabeth Berry-Kravis, Latha Soorya, Audrey Thurm, Craig M. Powell, Jonathan A. Bernstein, Alexander Kolevzon, Joseph D. Buxbaum

Summary: By analyzing the peripheral blood transcriptome and serum metabolome of individuals with Phelan-McDermid syndrome (PMS), researchers discovered gene expression profiles closely related to 22q13.3 deletion size. Additionally, they found underexpressed genes in PMS participants with class II mutations, not linked to 22q13.3, which were associated with glycosphingolipid metabolism, NCAM1 interactions, and cytotoxic natural killer (NK) immune cell signatures. This study provides new insights into the molecular perturbations and potential therapeutic targets for PMS.

HUMAN GENETICS AND GENOMICS ADVANCES (2023)

暂无数据